Proficio Capital Partners LLC bought a new stake in UiPath Inc. (NYSE:PATH – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 24,174 shares of the company’s stock, valued at approximately $307,000.
A number of other institutional investors have also modified their holdings of PATH. First Horizon Advisors Inc. boosted its position in shares of UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock worth $32,000 after acquiring an additional 804 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of UiPath by 33.4% during the 4th quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock worth $39,000 after acquiring an additional 759 shares in the last quarter. Quarry LP boosted its position in shares of UiPath by 654.4% during the 3rd quarter. Quarry LP now owns 3,146 shares of the company’s stock worth $40,000 after acquiring an additional 2,729 shares in the last quarter. True Wealth Design LLC boosted its position in shares of UiPath by 21,710.0% during the 3rd quarter. True Wealth Design LLC now owns 4,362 shares of the company’s stock worth $56,000 after acquiring an additional 4,342 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC acquired a new position in shares of UiPath during the 3rd quarter worth about $136,000. 62.50% of the stock is owned by institutional investors and hedge funds.
UiPath Trading Down 3.0 %
NYSE:PATH opened at $11.75 on Wednesday. The stock has a 50 day moving average of $13.48 and a 200-day moving average of $13.19. The firm has a market capitalization of $6.46 billion, a PE ratio of -73.41 and a beta of 1.00. UiPath Inc. has a 52 week low of $10.37 and a 52 week high of $25.47.
Insider Transactions at UiPath
Analyst Ratings Changes
Several analysts have commented on the company. Morgan Stanley upped their price objective on UiPath from $15.00 to $16.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Barclays reduced their price objective on UiPath from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, January 10th. UBS Group assumed coverage on UiPath in a research note on Thursday, December 12th. They set a “sell” rating and a $14.00 price objective for the company. BMO Capital Markets upped their price objective on UiPath from $15.00 to $16.00 and gave the company a “market perform” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Wednesday, January 15th. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $17.44.
Check Out Our Latest Stock Report on PATH
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
- Five stocks we like better than UiPath
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is a Bond Market Holiday? How to Invest and Trade
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Profitably Trade Stocks at 52-Week Highs
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.